Professor of Health Care Law at UCL, Prof Sir Jonathan Montgomery, said: “Legal proceedings are expected to provide further scrutiny” of the trial, adding: “If there are legal issues that the regulators have overlooked, then it is in everyone’s interests that these are clarified as soon as possible.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

New understanding of B cell mutation strategies could have implications for vaccines

A vaccine’s ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating in

Newport woman felt ‘so guilty’ having skin cancer while pregnant

A woman says she felt “so guilty” for having skin cancer while pregnant with her son. Emma Giannuzzi, 36, from Rogerstone, Newport, used sunbeds regularly in her late teens and

Employers are failing to insure the working class – Medicaid cuts would leave them even more vulnerable

The Congressional Budget Office estimates that 7.8 million Americans across the U.S. would lose their coverage through Medicaid – the public program that provides health insurance to low-income families and